Difference between revisions of "PEDS5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(One intermediate revision by the same user not shown)
Line 17: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|CHAPTER 2 (HAEMATOLYMPHOID DISORDERS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Chronic_myeloid_leukaemia_(CML)|Chronic myeloid leukaemia (CML)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Juvenile_myelomonocytic_leukaemia|Juvenile myelomonocytic leukaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Refractory_cytopenia_of_childhood|Refractory cytopenia of childhood]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myelodysplastic_syndrome_with_excess_blasts|Myelodysplastic syndrome with excess blasts]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Acute_myeloid_leukaemias_(AMLs)_defined_by_differentiation|Acute myeloid leukaemias (AMLs) defined by differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Acute_myeloid_leukaemias_(AMLs)_with_defining_genetic_abnormalities|Acute myeloid leukaemias (AMLs) with defining genetic abnormalities]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myeloid_neoplasms_associated_with_germline_predisposition_|Myeloid neoplasms associated with germline predisposition]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myeloid_proliferations_associated_with_Down_syndrome|Myeloid proliferations associated with Down syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mastocytosis|Mastocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:B-lymphoblastic_leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:T-_and_NK-lymphoblastic_leukaemia/lymphoma|T- and NK-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Primary_mediastinal_large_B-cell_lymphoma|Primary mediastinal large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_large_B-cell_lymphoma_NOS|Diffuse large B-cell lymphoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:EBV-positive_diffuse_large_B-cell_lymphoma|EBV-positive diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Large_B-cell_lymphoma_with_IRF4_rearrangement|Large B-cell lymphoma with IRF4 rearrangement]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric-type_follicular_lymphoma|Paediatric-type follicular lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric_nodal_marginal_zone_lymphoma|Paediatric nodal marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:ALK-positive_large_B-cell_lymphoma|ALK-positive large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mediastinal_grey_zone_lymphoma|Mediastinal grey zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Burkitt_lymphoma|Burkitt lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Large_B-cell_lymphoma_with_11q_aberration|Large B-cell lymphoma with 11q aberration]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Peripheral_T-cell_lymphoma_NOS|Peripheral T-cell lymphoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Aggressive_NK-cell_leukaemia|Aggressive NK-cell leukaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mycosis_fungoides|Mycosis fungoides]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Primary_cutaneous_CD30-positive_T-cell_lymphoproliferative_disorders|Primary cutaneous CD30-positive T-cell lymphoproliferative disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Subcutaneous_panniculitis-like_T-cell_lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:ALK-positive_anaplastic_large_cell_lymphoma|ALK-positive anaplastic large cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Systemic_EBV-positive_T-cell_lymphoma_of_childhood|Systemic EBV-positive T-cell lymphoma of childhood]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hydroa_vacciniforme_lymphoproliferative_disorder_|Hydroa vacciniforme lymphoproliferative disorder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Classic_Hodgkin_lymphoma|Classic Hodgkin lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Nodular_lymphocyte-predominant_Hodgkin_lymphoma|Nodular lymphocyte-predominant Hodgkin lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Langerhans_cell_histiocytosis_and_related_disorders|Langerhans cell histiocytosis and related disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Primary_immunodeficiency-associated_lymphoproliferative_disorders|Primary immunodeficiency-associated lymphoproliferative disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:HIV-associated_lymphoproliferative_disorders|HIV-associated lymphoproliferative disorders]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 3 (CNS TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Angiocentric_glioma|Angiocentric glioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered|Diffuse low-grade glioma, MAPK pathway-altered]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pilocytic_astrocytoma|Pilocytic astrocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ganglioglioma|Ganglioglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Supratentorial_ependymoma,_ZFTA_fusion-positive|Supratentorial ependymoma, ZFTA fusion-positive]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pineoblastoma|Pineoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 4 (PERIPHERAL NEUROBLASTIC TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Ganglioneuroma|Ganglioneuroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ganglioneuroblastoma,_intermixed|Ganglioneuroblastoma, intermixed]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Neuroblastoma|Neuroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ganglioneuroblastoma,_nodular_(and_other_composite_neuroblastic_tumours)|Ganglioneuroblastoma, nodular (and other composite neuroblastic tumours)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 5 (EYE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Epibulbar_choristoma|Epibulbar choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Phakomatous_choristoma|Phakomatous choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Conjunctival_junctional,_compound,_and_subepithelial_naevi|Conjunctival junctional, compound, and subepithelial naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Inflamed_juvenile_conjunctival_naevus|Inflamed juvenile conjunctival naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Diffuse_choroidal_neurofibroma_and_ganglioneuroma|Diffuse choroidal neurofibroma and ganglioneuroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lisch_nodule_(iris_hamartoma)|Lisch nodule (iris hamartoma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Retinocytoma|Retinocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Retinoblastoma|Retinoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Medulloepithelioma|Medulloepithelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pilocytic_astrocytoma_and_other_gliomas_of_the_optic_nerve|Pilocytic astrocytoma and other gliomas of the optic nerve]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 6 (SOFT TISSUE AND BONE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Lipomatosis|Lipomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lipoblastoma/lipoblastomatosis|Lipoblastoma/lipoblastomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Liposarcoma|Liposarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fasciitis/myositis|Fasciitis/myositis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibrodysplasia_ossificans_progressiva|Fibrodysplasia ossificans progressiva]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lipofibromatosis|Lipofibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Inclusion_body_infantile_digital_fibromatosis|Inclusion body infantile digital fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Juvenile_hyaline_fibromatosis_(hyaline_fibromatosis_syndrome)|Juvenile hyaline fibromatosis (hyaline fibromatosis syndrome)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibromatosis_colli|Fibromatosis colli]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sinonasal_angiofibroma|Sinonasal angiofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Plantar/palmar_fibromatoses|Plantar/palmar fibromatoses]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:EWSR1::SMAD3-positive_fibroblastic_tumour|EWSR1::SMAD3-positive fibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric_NTRK-rearranged_spindle_cell_neoplasm|Paediatric NTRK-rearranged spindle cell neoplasm]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Low-grade_fibromyxoid_sarcoma_/_sclerosing_epithelioid_fibrosarcoma|Low-grade fibromyxoid sarcoma / sclerosing epithelioid fibrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibrous_histiocytoma|Fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Plexiform_fibrohistiocytic_tumour_|Plexiform fibrohistiocytic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Capillary_malformations|Capillary malformations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Venous_malformations|Venous malformations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Arteriovenous_malformations|Arteriovenous malformations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Intramuscular_vascular_anomalies|Intramuscular vascular anomalies]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lymphatic_anomalies|Lymphatic anomalies]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Congenital_haemangioma|Congenital haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Infantile_haemangioma|Infantile haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Haemangioma_of_placenta|Haemangioma of placenta]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lobular_capillary_haemangioma_(pyogenic_granuloma)|Lobular capillary haemangioma (pyogenic granuloma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Papillary_intralymphatic_angioendothelioma_and_retiform_haemangioendothelioma|Papillary intralymphatic angioendothelioma and retiform haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myofibroma_and_myopericytoma|Myofibroma and myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Glomus_tumour_and_glomuvenous_malformation|Glomus tumour and glomuvenous malformation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Rhabdomyoma|Rhabdomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ectomesenchymoma|Ectomesenchymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Paediatric_gastrointestinal_stromal_tumour|Paediatric gastrointestinal stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Perineurioma|Perineurioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Intramuscular/juxta-articular_myxoma|Intramuscular/juxta-articular myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Superficial_angiomyxoma|Superficial angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Deep_angiomyxoma|Deep angiomyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:PEComa|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Myoepithelial_tumours_of_soft_tissue|Myoepithelial tumours of soft tissue]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Undifferentiated_sarcomas|Undifferentiated sarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Round_cell_sarcoma_with_EWSR1::non-ETS_fusions|Round cell sarcoma with EWSR1::non-ETS fusions]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 2,031:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 2,042:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Subungual_exostosis|Subungual exostosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 2,053:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 2,064:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Osteoblastoma|Osteoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 2,075:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Osteoid_osteoma|Osteoid osteoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 2,086:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Chondromesenchymal_hamartoma_of_the_chest_wall_|Chondromesenchymal hamartoma of the chest wall]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 2,097:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Osteosarcoma|Osteosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 2,108:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Chondroblastoma|Chondroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 2,119:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Osteochondroma|Osteochondroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 2,130:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 2,141:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Enchondroma_and_enchondromatosis|Enchondroma and enchondromatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 2,152:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Chondrosarcoma|Chondrosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 2,163:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Mesenchymal_chondrosarcoma_|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 2,174:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Vascular_tumours_of_bone_|Vascular tumours of bone]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 2,185:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 2,196:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Giant_cell_tumour_of_bone|Giant cell tumour of bone]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 2,207:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Notochordal_tumours|Notochordal tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Simple_bone_cyst_|Simple bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Adamantinoma|Adamantinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Osteofibrous_dysplasia|Osteofibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 7 (GERM CELL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Intratubular_germ_cell_neoplasia_(male_gonadal)|Intratubular germ cell neoplasia (male gonadal)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 2,304:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Gonadoblastoma|Gonadoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 2,315:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Germinoma/dysgerminoma/seminoma|Germinoma/dysgerminoma/seminoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 2,326:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Mature_cystic_teratoma|Mature cystic teratoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 2,337:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Extragonadal_teratoma|Extragonadal teratoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 2,348:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Monodermal_teratomas_(female_gonadal)|Monodermal teratomas (female gonadal)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 2,359:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Immature_teratoma_(female_gonadal)|Immature teratoma (female gonadal)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 2,370:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Prepubertal-type_testicular_teratoma|Prepubertal-type testicular teratoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 2,381:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Postpubertal-type_teratoma|Postpubertal-type teratoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 2,392:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Embryonal_carcinoma|Embryonal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 2,403:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Yolk_sac_tumour|Yolk sac tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 2,414:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Fetus_in_fetu|Fetus in fetu]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 2,425:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Choriocarcinoma_(non-gestational)|Choriocarcinoma (non-gestational)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 2,436:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Malignant_mixed_germ_cell_tumours|Malignant mixed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 2,447:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 8 (RENAL AND MALE GENITAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 2,478:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Nephroblastoma|Nephroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 2,489:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Renal_cell_carcinoma_with_MiT_translocations|Renal cell carcinoma with MiT translocations]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 2,500:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:ALK-rearranged_renal_cell_carcinoma|ALK-rearranged renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 2,511:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 2,522:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 2,533:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Metanephric_adenoma|Metanephric adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 2,544:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Metanephric_adenofibroma_|Metanephric adenofibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 2,555:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Metanephric_stromal_tumour|Metanephric stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 2,566:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 2,577:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Mesoblastic_nephroma|Mesoblastic nephroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 2,588:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 2,599:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Malignant_rhabdoid_tumour_of_the_kidney|Malignant rhabdoid tumour of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 2,610:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Anaplastic_sarcoma_of_the_kidney|Anaplastic sarcoma of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 2,621:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Renal_Ewing_sarcoma|Renal Ewing sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 2,632:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Juvenile_granulosa_cell_tumour_of_the_testis|Juvenile granulosa cell tumour of the testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 2,643:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 9 (FEMALE GENITAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Ovarian_fibroma|Ovarian fibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 2,674:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Sclerosing_stromal_tumour|Sclerosing stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 2,685:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Juvenile_granulosa_cell_tumour_of_the_ovary|Juvenile granulosa cell tumour of the ovary]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 2,696:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Sex_cord_tumour_with_annular_tubules_|Sex cord tumour with annular tubules]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 2,707:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Papillary_cystadenoma|Papillary cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 2,718:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Sertoli-Leydig_cell_tumour|Sertoli-Leydig cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 2,729:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Gynandroblastoma|Gynandroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 2,740:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Small_cell_carcinoma_of_the_ovary,_hypercalcaemic_type|Small cell carcinoma of the ovary, hypercalcaemic type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 2,751:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Mesonephric_remnants_and_hyperplasia|Mesonephric remnants and hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 2,762:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Mullerian_papilloma|Mullerian papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 2,773:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 2,784:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Peritoneal_inclusion_cysts_|Peritoneal inclusion cysts]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 2,795:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 10 (BREAST TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Fibroepithelial_tumours_|Fibroepithelial tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 2,826:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Juvenile_fibroadenoma|Juvenile fibroadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 2,837:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Juvenile_papillomatosis|Juvenile papillomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 2,848:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 11 (DIGESTIVE SYSTEM TUMOUR)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Hepatoblastoma|Hepatoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 2,879:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Fibrolamellar_variant_of_hepatocellular_carcinoma|Fibrolamellar variant of hepatocellular carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 2,890:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Paediatric_hepatocellular_carcinoma|Paediatric hepatocellular carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 2,901:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Mesenchymal_hamartoma|Mesenchymal hamartoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 2,912:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Calcifying_nested_stromal-epithelial_tumour|Calcifying nested stromal-epithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 2,923:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Embryonal_sarcoma_of_the_liver|Embryonal sarcoma of the liver]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 2,934:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Hepatic_congenital_haemangioma|Hepatic congenital haemangioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 2,945:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Hepatic_infantile_haemangioma|Hepatic infantile haemangioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 2,956:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Hepatic_angiosarcoma|Hepatic angiosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 2,967:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Pancreatoblastoma|Pancreatoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 2,978:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 2,989:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Solid_pseudopapillary_neoplasm|Solid pseudopapillary neoplasm]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 3,000:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[PEDS5:Gastroblastoma|Gastroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 3,011:
 
|
 
|
 
|-
 
|-
 +
|[[PEDS5:Appendiceal_neuroendocrine_tumours|Appendiceal neuroendocrine tumours]]
 +
|Disease
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 12 (ENDOCRINE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Follicular_adenoma_of_the_thyroid|Follicular adenoma of the thyroid]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Papillary_thyroid_carcinoma|Papillary thyroid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Medullary_thyroid_carcinoma|Medullary thyroid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Spindle_epithelial_tumour_with_thymus-like_elements|Spindle epithelial tumour with thymus-like elements]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Parathyroid_adenoma|Parathyroid adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Adrenal_cortical_tumours|Adrenal cortical tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sympathetic_paraganglioma|Sympathetic paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Parasympathetic_paraganglioma_(head_and_neck_paraganglioma)|Parasympathetic paraganglioma (head and neck paraganglioma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Phaeochromocytoma|Phaeochromocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Composite_phaeochromocytoma/paraganglioma|Composite phaeochromocytoma/paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Other_neuroendocrine_tumours|Other neuroendocrine tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 13 (HEAD AND NECK TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Squamous_cell_papilloma_of_the_larynx|Squamous cell papilloma of the larynx]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:White_sponge_naevus|White sponge naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Congenital_granular_cell_epulis|Congenital granular cell epulis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Central_giant_cell_granuloma|Central giant cell granuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Odontogenic_tumours|Odontogenic tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Ossifying_fibroma|Ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sinonasal_tract_myxoma|Sinonasal tract myxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Nasal_dermoid_cyst|Nasal dermoid cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Nasopharyngeal_dermoid|Nasopharyngeal dermoid]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sinonasal_chondromesenchymal_hamartoma|Sinonasal chondromesenchymal hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pleomorphic_adenoma|Pleomorphic adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Sialoblastoma|Sialoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Nasopharyngeal_carcinoma|Nasopharyngeal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:NUT_carcinoma|NUT carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Melanotic_neuroectodermal_tumour_of_infancy|Melanotic neuroectodermal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 14 (THORACIC TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Fetal_lung_interstitial_tumour|Fetal lung interstitial tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Congenital_peribronchial_myofibroblastic_tumour|Congenital peribronchial myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pleuropulmonary_blastoma|Pleuropulmonary blastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Cardiac_rhabdomyoma|Cardiac rhabdomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 15 (SKIN TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Hamartomas|Hamartomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Angiokeratoma|Angiokeratoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Epidermal_naevi|Epidermal naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pilomatricoma|Pilomatricoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Congenital_naevi|Congenital naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Junctional,_compound,_and_dermal_naevi|Junctional, compound, and dermal naevi]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Blue_naevus|Blue naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Spitz_naevus|Spitz naevus]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Pigmented_spindle_cell_naevus_(Reed_naevus)|Pigmented spindle cell naevus (Reed naevus)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Melanoma|Melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 16 (GENETIC TUMOUR SYNDROMES)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[PEDS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Retinoblastoma_syndrome|Retinoblastoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:WAGR_syndrome|WAGR syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Beckwith-Wiedemann_and_related_overgrowth_syndromes|Beckwith-Wiedemann and related overgrowth syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Familial_adenomatous_polyposis|Familial adenomatous polyposis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Lynch_syndrome|Lynch syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[PEDS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 09:03, 27 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Paediatric Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (HAEMATOLYMPHOID DISORDERS)
Chronic myeloid leukaemia (CML) Disease
Juvenile myelomonocytic leukaemia Disease
Refractory cytopenia of childhood Disease
Myelodysplastic syndrome with excess blasts Disease
Acute myeloid leukaemias (AMLs) defined by differentiation Disease
Acute myeloid leukaemias (AMLs) with defining genetic abnormalities Disease
Myeloid neoplasms associated with germline predisposition Disease
Myeloid proliferations associated with Down syndrome Disease
Mastocytosis Disease
B-lymphoblastic leukaemia/lymphoma Disease
T- and NK-lymphoblastic leukaemia/lymphoma Disease
Primary mediastinal large B-cell lymphoma Disease
Diffuse large B-cell lymphoma NOS Disease
EBV-positive diffuse large B-cell lymphoma Disease
Large B-cell lymphoma with IRF4 rearrangement Disease
Paediatric-type follicular lymphoma Disease
Paediatric nodal marginal zone lymphoma Disease
ALK-positive large B-cell lymphoma Disease
Lymphomatoid granulomatosis Disease
Plasmablastic lymphoma Disease
Mediastinal grey zone lymphoma Disease
Burkitt lymphoma Disease
Large B-cell lymphoma with 11q aberration Disease
Peripheral T-cell lymphoma NOS Disease
Aggressive NK-cell leukaemia Disease
Mycosis fungoides Disease
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders Disease
Subcutaneous panniculitis-like T-cell lymphoma Disease
ALK-positive anaplastic large cell lymphoma Disease
Hepatosplenic T-cell lymphoma Disease
Systemic EBV-positive T-cell lymphoma of childhood Disease
Hydroa vacciniforme lymphoproliferative disorder Disease
Classic Hodgkin lymphoma Disease
Nodular lymphocyte-predominant Hodgkin lymphoma Disease
Langerhans cell histiocytosis and related disorders Disease
Primary immunodeficiency-associated lymphoproliferative disorders Disease
Posttransplant lymphoproliferative disorders Disease
HIV-associated lymphoproliferative disorders Disease
CHAPTER 3 (CNS TUMOURS)
Diffuse astrocytoma, MYB- or MYBL1-altered Disease
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease
Diffuse midline glioma, H3 K27-altered Disease
Diffuse hemispheric glioma, H3 G34-mutant Disease
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease
Subependymal giant cell astrocytoma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
Medulloblastoma, WNT-activated Disease
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
Pineoblastoma Disease
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Adamantinomatous craniopharyngioma Disease
CHAPTER 4 (PERIPHERAL NEUROBLASTIC TUMOURS)
Ganglioneuroma Disease
Ganglioneuroblastoma, intermixed Disease
Neuroblastoma Disease
Ganglioneuroblastoma, nodular (and other composite neuroblastic tumours) Disease
CHAPTER 5 (EYE TUMOURS)
Epibulbar choristoma Disease
Epibulbar osseous choristoma Disease
Phakomatous choristoma Disease
Conjunctival junctional, compound, and subepithelial naevi Disease
Inflamed juvenile conjunctival naevus Disease
Diffuse choroidal neurofibroma and ganglioneuroma Disease
Lisch nodule (iris hamartoma) Disease
Retinocytoma Disease
Retinoblastoma Disease
Medulloepithelioma Disease
Pilocytic astrocytoma and other gliomas of the optic nerve Disease
CHAPTER 6 (SOFT TISSUE AND BONE TUMOURS)
Lipomatosis Disease
Lipoblastoma/lipoblastomatosis Disease
Liposarcoma Disease
Fasciitis/myositis Disease
Fibrodysplasia ossificans progressiva Disease
Fibroma of tendon sheath Disease
Gardner fibroma Disease
Fibrous hamartoma of infancy Disease
Lipofibromatosis Disease
Inclusion body infantile digital fibromatosis Disease
Juvenile hyaline fibromatosis (hyaline fibromatosis syndrome) Disease
Fibromatosis colli Disease
Calcifying aponeurotic fibroma Disease
Sinonasal angiofibroma Disease
Plantar/palmar fibromatoses Disease
Dermatofibrosarcoma protuberans Disease
Desmoid fibromatosis Disease
EWSR1::SMAD3-positive fibroblastic tumour Disease
Infantile fibrosarcoma Disease
Paediatric NTRK-rearranged spindle cell neoplasm Disease
Low-grade fibromyxoid sarcoma / sclerosing epithelioid fibrosarcoma Disease
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease
Fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease
Tenosynovial giant cell tumour Disease
Capillary malformations Disease
Venous malformations Disease
Arteriovenous malformations Disease
Intramuscular vascular anomalies Disease
Lymphatic anomalies Disease
Congenital haemangioma Disease
Infantile haemangioma Disease
Haemangioma of placenta Disease
Lobular capillary haemangioma (pyogenic granuloma) Disease
Epithelioid haemangioma Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Papillary intralymphatic angioendothelioma and retiform haemangioendothelioma Disease
Pseudomyogenic haemangioendothelioma Disease
Kaposi sarcoma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Myofibroma and myopericytoma Disease
Glomus tumour and glomuvenous malformation Disease
EBV-associated smooth muscle tumour Disease
Rhabdomyoma Disease
Rhabdomyosarcomas Disease
Ectomesenchymoma Disease
Paediatric gastrointestinal stromal tumour Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumour Disease
Granular cell tumour Disease
Solitary circumscribed neuroma Disease
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Malignant peripheral nerve sheath tumour Disease
Intramuscular/juxta-articular myxoma Disease
Superficial angiomyxoma Disease
Deep angiomyxoma Disease
Angiomatoid fibrous histiocytoma Disease
Clear cell sarcoma of soft tissue Disease
Alveolar soft part sarcoma Disease
Extrarenal rhabdoid tumour Disease
PEComa Disease
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Myoepithelial tumours of soft tissue Disease
Phosphaturic mesenchymal tumour Disease
Desmoplastic small round cell tumour Disease
Undifferentiated sarcomas Disease
Ewing sarcoma Disease
Round cell sarcoma with EWSR1::non-ETS fusions Disease
CIC-rearranged sarcoma Disease
Sarcoma with BCOR genetic alterations Disease
Subungual exostosis Disease
Bizarre parosteal osteochondromatous proliferation Disease
Osteoblastoma Disease
Osteoid osteoma Disease
Chondromesenchymal hamartoma of the chest wall Disease
Osteosarcoma Disease
Chondroblastoma Disease
Osteochondroma Disease
Chondromyxoid fibroma Disease
Enchondroma and enchondromatosis Disease
Chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Vascular tumours of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Notochordal tumours Disease
Simple bone cyst Disease
Adamantinoma Disease
Osteofibrous dysplasia Disease
Fibrous dysplasia Disease
CHAPTER 7 (GERM CELL TUMOURS)
Intratubular germ cell neoplasia (male gonadal) Disease
Gonadoblastoma Disease
Germinoma/dysgerminoma/seminoma Disease
Mature cystic teratoma Disease
Extragonadal teratoma Disease
Monodermal teratomas (female gonadal) Disease
Immature teratoma (female gonadal) Disease
Prepubertal-type testicular teratoma Disease
Postpubertal-type teratoma Disease
Embryonal carcinoma Disease
Yolk sac tumour Disease
Fetus in fetu Disease
Choriocarcinoma (non-gestational) Disease
Malignant mixed germ cell tumours Disease
CHAPTER 8 (RENAL AND MALE GENITAL TUMOURS)
Paediatric cystic nephroma Disease
Nephroblastoma Disease
Renal cell carcinoma with MiT translocations Disease
ALK-rearranged renal cell carcinoma Disease
Eosinophilic solid and cystic renal cell carcinoma Disease
SMARCB1-deficient renal medullary carcinoma Disease
Metanephric adenoma Disease
Metanephric adenofibroma Disease
Metanephric stromal tumour Disease
Ossifying renal tumour of infancy Disease
Mesoblastic nephroma Disease
Clear cell sarcoma of the kidney Disease
Malignant rhabdoid tumour of the kidney Disease
Anaplastic sarcoma of the kidney Disease
Renal Ewing sarcoma Disease
Juvenile granulosa cell tumour of the testis Disease
CHAPTER 9 (FEMALE GENITAL TUMOURS)
Ovarian fibroma Disease
Sclerosing stromal tumour Disease
Juvenile granulosa cell tumour of the ovary Disease
Sex cord tumour with annular tubules Disease
Papillary cystadenoma Disease
Sertoli-Leydig cell tumour Disease
Gynandroblastoma Disease
Small cell carcinoma of the ovary, hypercalcaemic type Disease
Mesonephric remnants and hyperplasia Disease
Mullerian papilloma Disease
Condyloma acuminatum Disease
Peritoneal inclusion cysts Disease
CHAPTER 10 (BREAST TUMOURS)
Fibroepithelial tumours Disease
Juvenile fibroadenoma Disease
Juvenile papillomatosis Disease
CHAPTER 11 (DIGESTIVE SYSTEM TUMOUR)
Hepatoblastoma Disease
Fibrolamellar variant of hepatocellular carcinoma Disease
Paediatric hepatocellular carcinoma Disease
Mesenchymal hamartoma Disease
Calcifying nested stromal-epithelial tumour Disease
Embryonal sarcoma of the liver Disease
Hepatic congenital haemangioma Disease
Hepatic infantile haemangioma Disease
Hepatic angiosarcoma Disease
Pancreatoblastoma Disease
Pancreatic acinar cell carcinoma Disease
Solid pseudopapillary neoplasm Disease
Gastroblastoma Disease
Appendiceal neuroendocrine tumours Disease
CHAPTER 12 (ENDOCRINE TUMOURS)
Follicular adenoma of the thyroid Disease
Papillary thyroid carcinoma Disease
Medullary thyroid carcinoma Disease
Spindle epithelial tumour with thymus-like elements Disease
Parathyroid adenoma Disease
Adrenal cortical tumours Disease
Sympathetic paraganglioma Disease
Parasympathetic paraganglioma (head and neck paraganglioma) Disease
Phaeochromocytoma Disease
Composite phaeochromocytoma/paraganglioma Disease
Other neuroendocrine tumours Disease
CHAPTER 13 (HEAD AND NECK TUMOURS)
Squamous cell papilloma of the larynx Disease
White sponge naevus Disease
Congenital granular cell epulis Disease
Central giant cell granuloma Disease
Odontogenic tumours Disease
Ossifying fibroma Disease
Sinonasal tract myxoma Disease
Nasal dermoid cyst Disease
Nasopharyngeal dermoid Disease
Sinonasal chondromesenchymal hamartoma Disease
Pleomorphic adenoma Disease
Mucoepidermoid carcinoma Disease
Acinic cell carcinoma Disease
Sialoblastoma Disease
Nasopharyngeal carcinoma Disease
NUT carcinoma Disease
Melanotic neuroectodermal tumour of infancy Disease
CHAPTER 14 (THORACIC TUMOURS)
Fetal lung interstitial tumour Disease
Congenital peribronchial myofibroblastic tumour Disease
Pleuropulmonary blastoma Disease
Cardiac rhabdomyoma Disease
CHAPTER 15 (SKIN TUMOURS)
Hamartomas Disease
Angiokeratoma Disease
Epidermal naevi Disease
Pilomatricoma Disease
Congenital naevi Disease
Junctional, compound, and dermal naevi Disease
Blue naevus Disease
Spitz naevus Disease
Pigmented spindle cell naevus (Reed naevus) Disease
Melanoma Disease
CHAPTER 16 (GENETIC TUMOUR SYNDROMES)
Neurofibromatosis type 1 Disease
Neurofibromatosis type 2 Disease
Tuberous sclerosis Disease
Naevoid basal cell carcinoma syndrome (Gorlin syndrome) Disease
Retinoblastoma syndrome Disease
Von Hippel-Lindau syndrome Disease
Hereditary phaeochromocytoma-paraganglioma syndromes Disease
WAGR syndrome Disease
Beckwith-Wiedemann and related overgrowth syndromes Disease
Familial adenomatous polyposis Disease
Lynch syndrome Disease
Xeroderma pigmentosum Disease
Rothmund-Thomson syndrome Disease
Li-Fraumeni syndrome Disease
DICER1 syndrome Disease
BAP1 tumour predisposition syndrome Disease
Constitutional mismatch repair deficiency syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Retrieved from "https://content.ccga.io/index.php?title=PEDS5:Volunteer_Assignments_and_Opportunities&oldid=14262"